|
|
|
Insider
Information: |
Roper Jess |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
46,497 |
|
Indirect Shares
|
8,452 |
|
|
Direct
Value |
$5,357,849 |
|
|
Indirect Value
|
$973,924 |
|
|
Total
Shares |
54,949 |
|
|
Total
Value |
$6,331,773 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
DexCom Inc |
DXCM |
SVP, CFO |
2017-03-22 |
46,497 |
2017-03-22 |
8,452 |
Premium* |
|
Biolase Inc |
BIOL |
Director |
2022-04-28 |
0 |
2022-04-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
94 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
DXCM |
DexCom Inc |
SVP, CFO |
|
2015-11-18 |
4 |
AS |
$83.99 |
$589,016 |
D/D |
(7,000) |
82,924 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2015-11-18 |
4 |
OE |
$9.80 |
$58,800 |
D/D |
6,000 |
84,414 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2015-12-22 |
4 |
AS |
$81.19 |
$277,417 |
D/D |
(3,417) |
79,507 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2016-01-22 |
4 |
AS |
$72.97 |
$256,700 |
D/D |
(3,518) |
75,989 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2016-03-08 |
4 |
A |
$0.00 |
$30 |
D/D |
30,000 |
106,298 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2016-03-10 |
4 |
D |
$63.18 |
$504,176 |
D/D |
(7,980) |
98,318 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2016-03-14 |
4 |
D |
$63.96 |
$170,009 |
D/D |
(2,658) |
95,660 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2016-03-31 |
4 |
AS |
$69.00 |
$239,430 |
D/D |
(3,470) |
92,190 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2016-04-25 |
4 |
AS |
$69.00 |
$239,499 |
D/D |
(3,471) |
88,719 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2016-06-07 |
4 |
AS |
$69.00 |
$239,500 |
D/D |
(3,471) |
85,248 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2016-09-09 |
4 |
D |
$93.72 |
$583,236 |
D/D |
(6,223) |
79,156 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2016-09-22 |
4 |
AS |
$93.99 |
$232,155 |
D/D |
(2,470) |
76,686 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2016-10-24 |
4 |
AS |
$80.75 |
$199,544 |
D/D |
(2,471) |
74,215 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2016-12-14 |
4 |
AS |
$64.14 |
$156,619 |
I/I |
(2,442) |
15,797 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2017-01-18 |
4 |
AS |
$85.01 |
$256,051 |
I/I |
(3,012) |
12,785 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2017-02-22 |
4 |
AS |
$78.76 |
$183,759 |
I/I |
(2,333) |
10,452 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2017-03-10 |
4 |
D |
$77.55 |
$744,951 |
D/D |
(9,606) |
46,497 |
0 |
- |
|
DXCM |
DexCom Inc |
SVP, CFO |
|
2017-03-22 |
4 |
AS |
$75.97 |
$151,937 |
I/I |
(2,000) |
8,452 |
0 |
- |
|
BIOL |
Biolase Inc |
Director |
|
2022-04-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(346) |
0 |
0 |
- |
|
94 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|